B. D. Abbott, Review of the expression of peroxisome proliferator-activated receptors alpha (PPAR??), beta (PPAR??), and gamma (PPAR??) in rodent and human development, Reproductive Toxicology, vol.27, issue.3-4, pp.246-257, 2009.
DOI : 10.1016/j.reprotox.2008.10.001

K. Abel, M. Waikar, B. Pedro, D. Hemsley, and M. Geyer, Repeated testing of prepulse inhibition and habituation of the startle reflex: a study in healthy human controls, Journal of Psychopharmacology, vol.41, issue.4, pp.330-337, 1998.
DOI : 10.1177/026988119801200402

S. E. Ahmari, V. B. Risbrough, M. A. Geyer, and H. B. Simpson, Impaired Sensorimotor Gating in Unmedicated Adults with Obsessive???Compulsive Disorder, Neuropsychopharmacology, vol.57, issue.5, pp.1216-1223, 2012.
DOI : 10.1038/npp.2011.308

P. Allen, G. Modinos, D. Hubl, G. Shields, A. Cachia et al., Neuroimaging Auditory Hallucinations in Schizophrenia: From Neuroanatomy to Neurochemistry and Beyond, Schizophrenia Bulletin, vol.38, issue.4, pp.695-703
DOI : 10.1093/schbul/sbs066

H. A. Allen, P. F. Liddle, and C. D. Frith, Negative features, retrieval processes and verbal fluency in schizophrenia, The British Journal of Psychiatry, vol.163, issue.6, pp.769-775, 1993.
DOI : 10.1192/bjp.163.6.769

M. Amargós-bosch, X. López-gil, F. Artigas, and A. Adell, Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine, The International Journal of Neuropsychopharmacology, vol.9, issue.05, pp.565-573, 2006.
DOI : 10.1017/S1461145705005900

. American-psychiatric-association, Diagnostic and statistical manual of mental disorders, 2000.
DOI : 10.1176/appi.books.9780890425596

G. P. Amminger, L. P. Henry, S. M. Harrigan, M. G. Harris, M. Alvarez-jimenez et al., Outcome in early-onset schizophrenia revisited: Findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study, Schizophrenia Research, vol.131, issue.1-3, pp.112-119, 2011.
DOI : 10.1016/j.schres.2011.06.009

N. E. Anden, A. Carlsson, A. Dahltroem, K. Fuxe, N. A. Hillarp et al., Demonstration and mapping out of nigro-neostriatal dopamine neurons, Life Sciences, vol.3, issue.6, pp.523-530, 1964.
DOI : 10.1016/0024-3205(64)90161-4

N. C. Andreasen and M. Flaum, Schizophrenia: The Characteristic Symptoms, Schizophrenia Bulletin, vol.17, issue.1, pp.27-49, 1991.
DOI : 10.1093/schbul/17.1.27

T. H. Andree, M. Mikuni, C. Y. Tong, J. I. Koenig, and H. Y. Meltzer, Receptors in Rat Cerebral Cortex, Journal of Neurochemistry, vol.1, issue.1, pp.191-197, 1986.
DOI : 10.1016/0165-0327(82)90002-7

N. Armstrong, Y. Sun, G. Q. Chen, and E. Gouaux, Structure of a glutamate-receptor ligand-binding core in complex with kainate, Nature, vol.395, pp.913-917, 1998.

R. J. Atkinson, P. T. Michie, and U. Schall, Duration Mismatch Negativity and P3a in First-Episode Psychosis and Individuals at Ultra-High Risk of Psychosis, Biological Psychiatry, vol.71, issue.2, pp.98-104, 2012.
DOI : 10.1016/j.biopsych.2011.08.023

V. P. Bakshi, N. R. Swerdlow, and M. A. Geyer, Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response, J. Pharmacol. Exp. Ther, vol.271, pp.787-794, 1994.

I. C. Ballard, V. P. Murty, R. M. Carter, J. J. Macinnes, S. A. Huettel et al., Dorsolateral Prefrontal Cortex Drives Mesolimbic Dopaminergic Regions to Initiate Motivated Behavior, Journal of Neuroscience, vol.31, issue.28, pp.10340-10346, 2011.
DOI : 10.1523/JNEUROSCI.0895-11.2011

G. Barbalat, V. Chambon, N. Franck, E. Koechlin, and C. Farrer, Organization of Cognitive Control Within the Lateral Prefrontal Cortex in Schizophrenia, Archives of General Psychiatry, vol.66, issue.4, pp.377-386, 2009.
DOI : 10.1001/archgenpsychiatry.2009.10

URL : https://hal.archives-ouvertes.fr/hal-00383710

D. M. Barch and A. Ceaser, Cognition in schizophrenia: core psychological and neural mechanisms, Trends in Cognitive Sciences, vol.16, issue.1, pp.27-34, 2012.
DOI : 10.1016/j.tics.2011.11.015

A. A. Baumeister and M. F. Hawkins, The Serotonin Hypothesis of Schizophrenia: A Historical Case Study on the Heuristic Value of Theory in Clinical Neuroscience, Journal of the History of the Neurosciences, vol.13, issue.3, pp.277-291, 2004.
DOI : 10.1080/09647040490510560

F. M. Benes, Emerging principles of altered neural circuitry in schizophrenia, Brain Research Reviews, vol.31, issue.2-3, pp.251-269, 2000.
DOI : 10.1016/S0165-0173(99)00041-7

S. J. Bensinger and P. Tontonoz, Integration of metabolism and inflammation by lipid-activated nuclear receptors, Nature, vol.109, issue.7203, pp.470-477, 2008.
DOI : 10.1038/nature07202

M. Berk, D. Copolov, O. Dean, K. Lu, S. Jeavons et al., N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia???A Double-Blind, Randomized, Placebo-Controlled Trial, Biological Psychiatry, vol.64, issue.5, pp.361-368, 2008.
DOI : 10.1016/j.biopsych.2008.03.004

B. K. Bitanihirwe and T. W. Woo, Oxidative stress in schizophrenia: An integrated approach, Neuroscience & Biobehavioral Reviews, vol.35, issue.3, pp.878-893, 2011.
DOI : 10.1016/j.neubiorev.2010.10.008

P. Bob and G. A. Mashour, Schizophrenia, dissociation, and consciousness, Consciousness and Cognition, vol.20, issue.4, pp.1042-1049, 2011.
DOI : 10.1016/j.concog.2011.04.013

R. Bordet, T. Ouk, O. Petrault, P. Gelé, S. Gautier et al., PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases, Biochemical Society Transactions, vol.34, issue.6, pp.1341-1346, 2006.
DOI : 10.1042/BST0341341

B. Khalil and R. , Recombinant human IGF-1 for patients with schizophrenia, Medical Hypotheses, vol.77, issue.3, pp.427-429, 2011.
DOI : 10.1016/j.mehy.2011.06.001

D. L. Braff, Prepulse Inhibition of the Startle Reflex: A Window on the Brain in Schizophrenia, Curr Top Behav Neurosci, vol.4, pp.349-371, 2010.
DOI : 10.1007/7854_2010_61

D. L. Braff, M. A. Geyer, and N. R. Swerdlow, Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies, Psychopharmacology, vol.156, issue.2-3, pp.234-258, 2001.
DOI : 10.1007/s002130100810

T. D. Buckman, A. S. Kling, S. Eiduson, M. S. Sutphin, and A. Steinberg, Glutathione peroxidase and CT scan abnormalities in schizophrenia, Biological Psychiatry, vol.22, issue.11, pp.1349-1356, 1987.
DOI : 10.1016/0006-3223(87)90069-2

T. D. Cannon, D. C. Glahn, J. Kim, T. G. Van-erp, K. Karlsgodt et al., Dorsolateral Prefrontal Cortex Activity During Maintenance and Manipulation of Information in Working Memory in Patients With Schizophrenia, Archives of General Psychiatry, vol.62, issue.10, pp.1071-1080, 2005.
DOI : 10.1001/archpsyc.62.10.1071

A. Carlsson, Evidence for a role of dopamine in extrapyramidal functions, Acta Neurovegetativa, vol.80, issue.Suppl. 185, pp.484-493, 1964.
DOI : 10.1007/BF01252144

V. Castagné, P. C. Moser, and R. D. Porsolt, Preclinical Behavioral Models for Predicting Antipsychotic Activity, Adv. Pharmacol, vol.57, pp.381-418, 2009.
DOI : 10.1016/S1054-3589(08)57010-4

A. J. Catenacci, D. D. Grove, W. A. Weiss, S. M. Fisher, A. M. Sismondo et al., EVALUATION OF PHENCYCLIDINE AS A PREANESTHETIC AND ANESTHETIC AGENT, Survey of Anesthesiology, vol.4, issue.6, pp.145-150, 1959.
DOI : 10.1097/00132586-196012000-00014

C. L. Caton, R. E. Drake, D. S. Hasin, B. Dominguez, P. E. Shrout et al., Differences Between Early-Phase Primary Psychotic Disorders With Concurrent Substance Use and Substance-Induced Psychoses, Archives of General Psychiatry, vol.62, issue.2, pp.137-145, 2005.
DOI : 10.1001/archpsyc.62.2.137

F. Cauda, A. E. Cavanna, F. Sacco, K. Duca, S. Geminiani et al., Functional Connectivity and Coactivation of the Nucleus Accumbens: A Combined Functional Connectivity and Structure-Based Meta-analysis, Journal of Cognitive Neuroscience, vol.3, issue.10, pp.2864-2877, 2011.
DOI : 10.1152/jn.90463.2008

W. C. Chang, C. L. Hui, J. Y. Tang, G. H. Wong, M. M. Lam et al., Persistent negative symptoms in first-episode schizophrenia: A prospective three-year follow-up study, Schizophrenia Research, vol.133, issue.1-3, pp.22-28, 2011.
DOI : 10.1016/j.schres.2011.09.006

G. Chen, P. Greengard, and Z. Yan, Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex, Proceedings of the National Academy of Sciences, vol.101, issue.8, pp.2596-2600, 2004.
DOI : 10.1073/pnas.0308618100

D. W. Choi, Glutamate neurotoxicity in cortical cell culture is calcium dependent, Neuroscience Letters, vol.58, issue.3, pp.293-297, 1985.
DOI : 10.1016/0304-3940(85)90069-2

A. Cimini, E. Benedetti, L. Cristiano, P. Sebastiani, M. A. D-'amico et al., Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons, Neuroscience, vol.130, issue.2, pp.325-337, 2005.
DOI : 10.1016/j.neuroscience.2004.09.043

B. D. Cohen, G. Rosenbaum, E. D. Luby, and J. S. Gottlieb, Comparison of Phencyclidine Hydrochloride (Sernyl) with Other Drugs, Archives of General Psychiatry, vol.6, issue.5, pp.395-401, 1962.
DOI : 10.1001/archpsyc.1962.01710230063007

M. Collino, M. Aragno, R. Mastrocola, M. Gallicchio, A. C. Rosa et al., Modulation of the oxidative stress and inflammatory response by PPAR-?? agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion, European Journal of Pharmacology, vol.530, issue.1-2, pp.70-80, 2006.
DOI : 10.1016/j.ejphar.2005.11.049

B. Costall and R. J. Naylor, Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine, European Journal of Pharmacology, vol.35, issue.1, pp.161-168, 1976.
DOI : 10.1016/0014-2999(76)90311-3

K. A. Cunningham and J. B. Appel, Neuropharmacological reassessment of the discriminative stimulus properties ofd-lysergic acid diethylamide (LSD), Psychopharmacology, vol.76, issue.1, pp.67-73, 1987.
DOI : 10.1007/BF00690929

S. S. Dadras, W. S. Cook, A. V. Yeldandi, W. Q. Cao, M. S. Rao et al., Peroxisome Proliferator-Activated Receptor ??-Dependent Induction of Cell Surface Antigen Ly-6D Gene in the Mouse Liver, Gene Expression, vol.9, issue.4, pp.173-181, 2001.
DOI : 10.3727/000000001783992579

G. N. Dakhale, S. D. Khanzode, S. S. Khanzode, and A. Saoji, Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia, Psychopharmacology, vol.268, issue.4, pp.494-498, 2005.
DOI : 10.1007/s00213-005-0117-1

C. N. David, D. Greenstein, L. Clasen, P. Gochman, R. Miller et al., Childhood Onset Schizophrenia: High Rate of Visual Hallucinations, Journal of the American Academy of Child & Adolescent Psychiatry, vol.50, issue.7, pp.681-686, 2011.
DOI : 10.1016/j.jaac.2011.03.020

K. L. Davis, R. S. Kahn, G. Ko, and M. Davidson, Dopamine in schizophrenia: a review and reconceptualization, Am J Psychiatry, vol.148, pp.1474-1486, 1991.

B. Dean, T. Hussain, W. Hayes, E. Scarr, S. Kitsoulis et al., Changes in Serotonin2A and GABAA Receptors in Schizophrenia. Studies on the Human Dorsolateral Prefrontal Cortex, Journal of Neurochemistry, vol.72, issue.4, pp.1593-1599, 1999.
DOI : 10.1046/j.1471-4159.1999.721593.x

J. Delay and P. Deniker, Neuroleptic effects of chlorpromazine in therapeutics of neuropsychiatry, J Clin Exp Psychopathol, vol.16, pp.104-112, 1955.

D. Deplanque, P. Gelé, O. Pétrault, I. Six, C. Furman et al., Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment, J. Neurosci, vol.23, pp.6264-6271, 2003.

C. Dubertret and P. Gorwood, The French concept of " psychose hallucinatoire chronique " -a preliminary form of schizophrenia? The role of late-life psychosis in the anticipation hypothesis of schizophrenia, Dialogues Clin Neurosci, vol.3, pp.296-303, 2001.

W. W. Eaton, R. Thara, B. Federman, B. Melton, and K. Y. Liang, Structure and Course of Positive and Negative Symptoms in Schizophrenia, Archives of General Psychiatry, vol.52, issue.2, pp.127-134, 1995.
DOI : 10.1001/archpsyc.1995.03950140045005

O. Ekinci, Y. Albayrak, and A. Ekinci, Cognitive Insight and Its Relationship With Symptoms in Deficit and Nondeficit Schizophrenia, The Journal of Nervous and Mental Disease, vol.200, issue.1, pp.44-50, 2012.
DOI : 10.1097/NMD.0b013e31823e66af

F. Ellenberger, De la démence précoce à la schizophrénie [WWW Document]. Encyclopédie de L'Agora, 2012.

G. I. Elmer, J. Sydnor, H. Guard, E. Hercher, and M. W. Vogel, Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia, Psychopharmacology, vol.174, issue.2, pp.177-189, 2004.
DOI : 10.1007/s00213-003-1757-7

T. Enkel and M. Koch, Chronic corticosterone treatment impairs trace conditioning in rats with a neonatal medial prefrontal cortex lesion, Behavioural Brain Research, vol.203, issue.2, pp.173-179, 2009.
DOI : 10.1016/j.bbr.2009.04.033

G. Faludi and K. Mirnics, Synaptic changes in the brain of subjects with schizophrenia, International Journal of Developmental Neuroscience, vol.29, issue.3, pp.305-309, 2011.
DOI : 10.1016/j.ijdevneu.2011.02.013

A. A. Farooqui, W. Ong, and L. A. Horrocks, Endogenous Antioxidant Mechanisms and Glutamate Neurotoxicity, pp.205-240, 2008.
DOI : 10.1007/978-0-387-73023-3_9

S. H. Fatemi and T. D. Folsom, The Neurodevelopmental Hypothesis of Schizophrenia, Revisited, Schizophrenia Bulletin, vol.35, issue.3, pp.528-548, 2009.
DOI : 10.1093/schbul/sbn187

A. Frandsen, J. Drejer, and A. Schousboe, Direct Evidence That Excitotoxicity in Cultured Neurons Is Mediated via N-Methyl-D-Aspartate (NMDA) as well as Non-NMDA Receptors, Journal of Neurochemistry, vol.42, issue.1, pp.297-299, 1989.
DOI : 10.1016/0898-6568(89)90019-3

K. J. Friston, J. Ashburner, S. J. Kiebel, T. E. Nichols, and W. Penny, Statistical Parametric Mapping: The Analysis of Functional Brain Images, 2007.

P. Fusar-poli and G. Berger, Eicosapentaenoic Acid Interventions in Schizophrenia, Journal of Clinical Psychopharmacology, vol.32, issue.2, pp.179-185, 2012.
DOI : 10.1097/JCP.0b013e318248b7bb

W. Gaebel and J. Zielasek, Future classification of psychotic disorders, European Archives of Psychiatry and Clinical Neuroscience, vol.258, issue.Suppl 5, pp.213-218, 2009.
DOI : 10.1007/s00406-009-0049-6

S. Galderisi, A. Mucci, I. Bitter, J. Libiger, P. Bucci et al., For The Eufest Study Group, 2012. Persistent negative symptoms in first episode patients with schizophrenia: Results from the European First Episode Schizophrenia Trial, European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology

J. Garrabé, Henri Ey et la pensée psychiatrique contemporaine, 1997.

C. Gaser, I. Nenadic, H. P. Volz, C. Büchel, and H. Sauer, Neuroanatomy of 'Hearing Voices': A Frontotemporal Brain Structural Abnormality Associated with Auditory Hallucinations in Schizophrenia, Cerebral Cortex, vol.14, issue.1, pp.91-97, 2004.
DOI : 10.1093/cercor/bhg107

P. Gelosa, C. Banfi, A. Gianella, M. Brioschi, A. Pignieri et al., Peroxisome Proliferator-Activated Receptor ?? Agonism Prevents Renal Damage and the Oxidative Stress and Inflammatory Processes Affecting the Brains of Stroke-Prone Rats, Journal of Pharmacology and Experimental Therapeutics, vol.335, issue.2, pp.324-331, 2010.
DOI : 10.1124/jpet.110.171090

C. R. Genovese, N. A. Lazar, and T. Nichols, Thresholding of Statistical Maps in Functional Neuroimaging Using the False Discovery Rate, NeuroImage, vol.15, issue.4, pp.870-878, 2002.
DOI : 10.1006/nimg.2001.1037

M. A. Geyer and F. X. Vollenweider, Serotonin research: contributions to understanding psychoses, Trends in Pharmacological Sciences, vol.29, issue.9, pp.445-453, 2008.
DOI : 10.1016/j.tips.2008.06.006

C. Girard, M. Simard, R. Noiseux, L. Laplante, M. Dugas et al., Late-onset-psychosis: cognition, International Psychogeriatrics, vol.99, issue.08, pp.1301-1316, 2011.
DOI : 10.1017/S135561770000014X

J. Gjessing, Ketamine?? (Cl-581) in Clinical Anaesthesia, Acta Anaesthesiologica Scandinavica, vol.8, issue.1, pp.15-21, 1968.
DOI : 10.1111/j.1399-6576.1968.tb05452.x

R. Gonzalez-aparicio, J. A. Flores, I. Tasset, I. Tunez, and E. Fernandez-espejo, Mice lacking the peroxisome proliferator-activated receptor alpha gene present reduced number of dopamine neurons in the substantia nigra without altering motor behavior or dopamine neuron decline over life, Neuroscience, vol.186, pp.161-169, 2011.
DOI : 10.1016/j.neuroscience.2011.03.062

J. González-maeso and S. C. Sealfon, Psychedelics and schizophrenia, Trends in Neurosciences, vol.32, issue.4, pp.225-232, 2009.
DOI : 10.1016/j.tins.2008.12.005

F. H. Greig, S. Kennedy, and C. M. Spickett, Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation. Free Radic, Biol. Med, vol.52, pp.266-280, 2012.

Y. Grodzinsky and A. Santi, The battle for Broca???s region, Trends in Cognitive Sciences, vol.12, issue.12, pp.474-80, 2008.
DOI : 10.1016/j.tics.2008.09.001

H. Gronemeyer, J. Gustafsson, and V. Laudet, Principles for modulation of the nuclear receptor superfamily, Nature Reviews Drug Discovery, vol.97, issue.11, pp.950-964, 2004.
DOI : 10.1242/jcs.00247

J. Hanaway, J. A. Mcconnell, and M. G. Netsky, Histogenesis of the substantia nigra, ventral tegmental area of Tsai and interpeduncular nucleus: An autoradiographic study of the mesencephalon in the rat, The Journal of Comparative Neurology, vol.39, issue.1, pp.59-73, 1971.
DOI : 10.1002/cne.901420105

K. L. Hannan, S. J. Wood, A. R. Yung, D. Velakoulis, L. J. Phillips et al., Caudate nucleus volume in individuals at ultra-high risk of psychosis: A cross-sectional magnetic resonance imaging study, Psychiatry Research: Neuroimaging, vol.182, issue.3, pp.223-230, 2010.
DOI : 10.1016/j.pscychresns.2010.02.006

S. L. Hazen and G. M. Chisolm, Oxidized phosphatidylcholines: Pattern recognition ligands for multiple pathways of the innate immune response, Proceedings of the National Academy of Sciences, vol.99, issue.20, pp.12515-12517, 2002.
DOI : 10.1073/pnas.212532799

D. M. Helmeste and P. Seeman, Amphetamine-induced hypolocomotion in mice with more brain D2 dopamine receptors, Psychiatry Research, vol.7, issue.3, pp.351-359, 1982.
DOI : 10.1016/0165-1781(82)90072-5

R. E. Hoffman, T. Fernandez, B. Pittman, and M. Hampson, Elevated Functional Connectivity Along a Corticostriatal Loop and the Mechanism of Auditory/Verbal Hallucinations in Patients with Schizophrenia, Biological Psychiatry, vol.69, issue.5, pp.407-421, 2011.
DOI : 10.1016/j.biopsych.2010.09.050

O. D. Howes, J. Kambeitz, E. Kim, D. Stahl, M. Slifstein et al., The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment, Archives of General Psychiatry, vol.69, issue.8, 2012.
DOI : 10.1001/archgenpsychiatry.2012.169

O. D. Howes and S. Kapur, The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway, Schizophrenia Bulletin, vol.35, issue.3, pp.549-562, 2009.
DOI : 10.1093/schbul/sbp006

J. G. Howland, D. K. Hannesson, and A. G. Phillips, Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats, European Journal of Neuroscience, vol.29, issue.10, pp.2639-2648, 2004.
DOI : 10.1016/S0165-3806(97)00050-3

A. Iglewicz, T. W. Meeks, and D. V. Jeste, New Wine in Old Bottle: Late-life Psychosis, Psychiatric Clinics of North America, vol.34, issue.2, pp.295-318, 2011.
DOI : 10.1016/j.psc.2011.02.008

R. Jardri, P. Thomas, C. Delmaire, P. Delion, and D. Pins, The Neurodynamic Organization of Modality-Dependent Hallucinations, Cerebral Cortex, vol.23, issue.5, 2012.
DOI : 10.1093/cercor/bhs082

R. Jardri, A. Pouchet, D. Pins, and P. Thomas, Cortical Activations During Auditory Verbal Hallucinations in Schizophrenia: A Coordinate-Based Meta-Analysis, American Journal of Psychiatry, vol.168, issue.1, pp.73-81, 2011.
DOI : 10.1176/appi.ajp.2010.09101522

E. A. Jeong, B. T. Jeon, H. J. Shin, N. Kim, D. H. Lee et al., Ketogenic diet-induced peroxisome proliferator-activated receptor-?? activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures, Experimental Neurology, vol.232, issue.2, pp.195-202, 2011.
DOI : 10.1016/j.expneurol.2011.09.001

C. A. Jones, D. J. Watson, and K. C. Fone, Animal models of schizophrenia, British Journal of Pharmacology, vol.28, issue.4, pp.1162-1194, 2011.
DOI : 10.1111/j.1476-5381.2011.01386.x

W. H. Jung, J. S. Kim, J. H. Jang, J. Choi, M. H. Jung et al., Cortical Thickness Reduction in Individuals at Ultra-High-Risk for Psychosis, Schizophrenia Bulletin, vol.37, issue.4, pp.839-849, 2011.
DOI : 10.1093/schbul/sbp151

M. E. Kalaitzakis, L. M. Christian, L. B. Moran, M. B. Graeber, R. K. Pearce et al., Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease, Parkinsonism & Related Disorders, vol.15, issue.3, pp.196-204, 2009.
DOI : 10.1016/j.parkreldis.2008.05.007

S. R. Kay, A. Fiszbein, and L. A. Opler, The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia, Schizophrenia Bulletin, vol.13, issue.2, pp.261-276, 1987.
DOI : 10.1093/schbul/13.2.261

L. S. Kegeles, A. Abi-dargham, W. G. Frankle, R. Gil, T. B. Cooper et al., Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia, Archives of General Psychiatry, vol.67, issue.3, pp.231-239, 2010.
DOI : 10.1001/archgenpsychiatry.2010.10

M. S. Keshavan, S. Anderson, and J. W. Pettegrew, Is Schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited, Journal of Psychiatric Research, vol.28, issue.3, pp.239-265, 1994.
DOI : 10.1016/0022-3956(94)90009-4

C. D. Kilts, The changing roles and targets for animal models of schizophrenia, Biological Psychiatry, vol.50, issue.11, pp.845-855, 2001.
DOI : 10.1016/S0006-3223(01)01286-0

M. B. Knable and D. R. Weinberger, Dopamine, the prefrontal cortex and schizophrenia, Journal of Psychopharmacology, vol.14, issue.232, pp.123-131, 1997.
DOI : 10.1177/026988119701100205

H. Koikegami, Y. Hirata, and J. Oguma, Studies on the paralimbic brain structures. I. Definition and delimitation of the paralimbic brain structures and some experiments on the nucleus accumbens, Folia Psychiatr Neurol Jpn, vol.21, pp.151-180, 1967.

V. Kumari, E. Antonova, E. Zachariah, A. Galea, I. Aasen et al., Structural brain correlates of prepulse inhibition of the acoustic startle response in healthy humans, NeuroImage, vol.26, issue.4, pp.1052-1060, 2005.
DOI : 10.1016/j.neuroimage.2005.03.002

V. Kumari, O. F. Mulligan, P. A. Cotter, L. Poon, B. K. Toone et al., Effects of single oral administrations of haloperidol and d-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers, Behavioural Pharmacology, vol.9, issue.7, pp.567-576, 1998.
DOI : 10.1097/00008877-199811000-00012

J. Kung and R. R. Henry, Thiazolidinedione safety, Expert Opinion on Drug Safety, vol.50, issue.5, pp.565-579, 2012.
DOI : 10.1016/j.ijcard.2010.08.037

J. L. Lancaster, M. G. Woldorff, L. M. Parsons, M. Liotti, C. S. Freitas et al., Automated Talairach Atlas labels for functional brain mapping, Human Brain Mapping, vol.5, issue.3, pp.120-131, 2000.
DOI : 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8

V. Laudet and H. Gronemeyer, The Nuclear Receptor FactsBook, 2001.

S. E. Lauri, M. Segerstråle, A. Vesikansa, F. Maingret, C. Mulle et al., Endogenous Activation of Kainate Receptors Regulates Glutamate Release and Network Activity in the Developing Hippocampus, Journal of Neuroscience, vol.25, issue.18, pp.4473-4484, 2005.
DOI : 10.1523/JNEUROSCI.4050-04.2005

S. Lavoie, M. M. Murray, P. Deppen, M. G. Knyazeva, M. Berk et al., Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients, Neuropsychopharmacology, vol.22, issue.9, pp.2187-2199, 2008.
DOI : 10.1001/archpsyc.57.12.1139

L. Pen, G. Kew, J. Alberati, D. Borroni, E. Heitz et al., Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal???lesioned rats: reversal by glycine and a glycine transporter inhibitor, Biological Psychiatry, vol.54, issue.11, pp.1162-1170, 2003.
DOI : 10.1016/S0006-3223(03)00374-3

S. Leung, R. J. Croft, V. Guille, K. Scholes, B. V. O-'neill et al., Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants, Psychopharmacology, vol.87, issue.Suppl 1, pp.233-244, 2010.
DOI : 10.1007/s00213-009-1723-0

D. A. Lewis, J. N. Pierri, D. W. Volk, D. S. Melchitzky, and T. U. Woo, Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia, Biological Psychiatry, vol.46, issue.5, pp.616-626, 1999.
DOI : 10.1016/S0006-3223(99)00061-X

J. E. Leysen, P. M. Janssen, A. Schotte, W. H. Luyten, and A. A. Megens, Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors, Psychopharmacology, vol.20, issue.S1, pp.40-54, 1993.
DOI : 10.1007/BF02245006

J. A. Lieberman, Is schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective, Biological Psychiatry, vol.46, issue.6, pp.729-739, 1999.
DOI : 10.1016/S0006-3223(99)00147-X

B. K. Lipska, Neonatal disconnection of the rat hippocampus: a neurodevelopmental model of schizophrenia, Dialogues in Clinical Neuroscience, vol.4, p.361, 2002.

B. K. Lipska, G. E. Jaskiw, and D. R. Weinberger, Postpubertal Emergence of Hyperresponsiveness to Stress and to Amphetamine after Neonatal Excitotoxic Hippocampal Damage: A Potential Animal Model of Schizophrenia, Neuropsychopharmacology, vol.9, issue.1, pp.67-75, 1993.
DOI : 10.1038/npp.1993.44

B. K. Lipska, N. R. Swerdlow, M. A. Geyer, G. E. Jaskiw, D. L. Braff et al., Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine, Psychopharmacology, vol.10, issue.1, pp.35-43, 1995.
DOI : 10.1007/BF02246439

B. K. Lipska and D. R. Weinberger, Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats., Proceedings of the National Academy of Sciences, vol.92, issue.19, pp.8906-8910, 1995.
DOI : 10.1073/pnas.92.19.8906

F. López-muñoz, C. Alamo, E. Cuenca, W. W. Shen, P. Clervoy et al., History of the Discovery and Clinical Introduction of Chlorpromazine, Annals of Clinical Psychiatry, vol.41, issue.2, pp.113-135, 2005.
DOI : 10.1080/10401230591002002

R. E. Lubow and A. U. Moore, Latent inhibition: The effect of nonreinforced pre-exposure to the conditional stimulus., Journal of Comparative and Physiological Psychology, vol.52, issue.4, pp.415-419, 1959.
DOI : 10.1037/h0046700

J. Mäkinen, J. Miettunen, M. Isohanni, and H. Koponen, Negative symptoms in schizophrenia???A review, Nordic Journal of Psychiatry, vol.56, issue.1, 2008.
DOI : 10.1001/archpsyc.60.6.553

D. Malaspina, Schizophrenia: A Neurodevelopmental or a Neurodegenerative Disorder, The Journal of Clinical Psychiatry, vol.67, issue.08, p.7, 2006.
DOI : 10.4088/JCP.0806e07

K. Marche, T. Danel, and R. Bordet, Fetal alcohol-induced hyperactivity is reversed by treatment with the PPAR?? agonist fenofibrate in a rat model, Psychopharmacology, vol.26, issue.4???6, pp.285-296, 2011.
DOI : 10.1007/s00213-010-1960-2

L. J. Martin, N. A. Al-abdulla, A. M. Brambrink, J. R. Kirsch, F. E. Sieber et al., Neurodegeneration in Excitotoxicity, Global Cerebral Ischemia, and Target Deprivation: A Perspective on the Contributions of Apoptosis and Necrosis, Brain Research Bulletin, vol.46, issue.4, pp.281-309, 1998.
DOI : 10.1016/S0361-9230(98)00024-0

S. Matsubara and H. Y. Meltzer, Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex, Life Sciences, vol.45, issue.15, pp.1397-1406, 1989.
DOI : 10.1016/0024-3205(89)90027-1

R. Matz, W. Rick, H. Thompson, and S. Gershon, Clozapine--a potential antipsychotic agent without extrapyramidal manifestations, Curr Ther Res Clin Exp, vol.16, pp.687-695, 1974.

T. H. Mcglashan and R. E. Hoffman, Schizophrenia as a Disorder of Developmentally Reduced Synaptic Connectivity, Archives of General Psychiatry, vol.57, issue.7, pp.637-648, 2000.
DOI : 10.1001/archpsyc.57.7.637

P. Mcgorry, Transition to Adulthood: The Critical Period for Pre-emptive, Disease-modifying Care for Schizophrenia and Related Disorders, Schizophrenia Bulletin, vol.37, issue.3, pp.524-530, 2011.
DOI : 10.1093/schbul/sbr027

P. D. Mcgorry, A. R. Yung, L. J. Phillips, H. P. Yuen, S. Francey et al., Randomized Controlled Trial of Interventions Designed to Reduce the Risk of Progression to First-Episode Psychosis in a Clinical Sample With Subthreshold Symptoms, Archives of General Psychiatry, vol.59, issue.10, pp.921-928, 2002.
DOI : 10.1001/archpsyc.59.10.921

B. S. Meldrum, Glutamate as a neurotransmitter in the brain: review of physiology and pathology, J. Nutr, vol.130, pp.1007-1022, 2000.

M. Melis, S. Carta, L. Fattore, S. Tolu, S. Yasar et al., Peroxisome Proliferator-Activated Receptors-Alpha Modulate Dopamine Cell Activity Through Nicotinic Receptors, Biological Psychiatry, vol.68, issue.3, pp.256-264, 2010.
DOI : 10.1016/j.biopsych.2010.04.016

URL : https://hal.archives-ouvertes.fr/pasteur-00510400

H. Y. Meltzer, The importance of serotonin-dopamine interactions in the action of clozapine, Br J Psychiatry, 1992.

P. Milev, B. Ho, S. Arndt, and N. C. Andreasen, Predictive Values of Neurocognition and Negative Symptoms on Functional Outcome in Schizophrenia: A Longitudinal First-Episode Study With 7-Year Follow-Up, American Journal of Psychiatry, vol.162, issue.3, 2005.
DOI : 10.1176/appi.ajp.162.3.495

E. Mitford, R. Reay, K. Mccabe, R. Paxton, and D. Turkington, Ageism in first episode psychosis, International Journal of Geriatric Psychiatry, vol.24, issue.3, pp.1112-1118, 2010.
DOI : 10.1002/gps.2437

B. Moghaddam and D. Javitt, From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment, Neuropsychopharmacology, vol.35, issue.1, 2011.
DOI : 10.1073/pnas.76.10.5372

S. Moreno, S. Farioli-vecchioli, and M. P. Cerù, Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS, Neuroscience, vol.123, issue.1, pp.131-145, 2004.
DOI : 10.1016/j.neuroscience.2003.08.064

R. Morstyn, F. H. Duffy, and R. W. Mccarley, Altered P300 Topography in Schizophrenia, Archives of General Psychiatry, vol.40, issue.7, pp.729-734, 1983.
DOI : 10.1001/archpsyc.1983.01790060027003

Q. Mu, K. Johnson, P. S. Morgan, E. L. Grenesko, C. E. Molnar et al., A single 20??mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia, Schizophrenia Research, vol.94, issue.1-3, pp.332-341, 2007.
DOI : 10.1016/j.schres.2007.03.033

A. Nieoullon, Dopamine and the regulation of cognition and attention, Progress in Neurobiology, vol.67, issue.1, pp.53-83, 2002.
DOI : 10.1016/S0301-0082(02)00011-4

URL : https://hal.archives-ouvertes.fr/hal-00307886

V. Oertel, A. Rotarska-jagiela, V. G. Van-de-ven, C. Haenschel, K. Maurer et al., Visual hallucinations in schizophrenia investigated with functional magnetic resonance imaging, Psychiatry Research: Neuroimaging, vol.156, issue.3, pp.269-73, 2007.
DOI : 10.1016/j.pscychresns.2007.09.004

O. Neill, M. F. Shaw, and G. , Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D 1 agonist C-APB in mice, Psychopharmacology, vol.145, issue.3, pp.237-250, 1999.
DOI : 10.1007/s002130051055

Y. Okubo, T. Suhara, K. Suzuki, K. Kobayashi, O. Inoue et al., Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET, Nature, vol.385, issue.6617, pp.634-636, 1997.
DOI : 10.1038/385634a0

A. Paparelli, D. Forti, M. Morrison, P. D. Murray, and R. M. , Drug-Induced Psychosis: How to Avoid Star Gazing in Schizophrenia Research by Looking at More Obvious Sources of Light, Frontiers in Behavioral Neuroscience, vol.5, issue.1, 2011.
DOI : 10.3389/fnbeh.2011.00001

A. R. Patten, P. S. Brocardo, and B. R. Christie, Omega-3 supplementation can restore glutathione levels and prevent oxidative damage caused by prenatal ethanol exposure, The Journal of Nutritional Biochemistry, vol.24, issue.5, 2012.
DOI : 10.1016/j.jnutbio.2012.04.003

E. Perez-costas, M. Melendez-ferro, and R. C. Roberts, Basal ganglia pathology in schizophrenia: dopamine connections and anomalies, Journal of Neurochemistry, vol.29, issue.Suppl, pp.287-302, 2010.
DOI : 10.1111/j.1471-4159.2010.06604.x

H. Picard, I. Amado, S. Mouchet-mages, J. Olié, and M. Krebs, The Role of the Cerebellum in Schizophrenia: an Update of Clinical, Cognitive, and Functional Evidences, Schizophrenia Bulletin, vol.34, issue.1, pp.155-172, 2008.
DOI : 10.1093/schbul/sbm049

N. V. Radonji?, I. D. Knezevi?, U. Vilimanovich, T. Kravi?-stevovi?, L. V. Marina et al., Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration, Neuropharmacology, vol.58, issue.4-5, pp.739-745, 2010.
DOI : 10.1016/j.neuropharm.2009.12.009

T. K. Rajji, Z. Ismail, and B. H. Mulsant, Age at onset and cognition in schizophrenia: meta-analysis, The British Journal of Psychiatry, vol.195, issue.4, pp.286-293, 2009.
DOI : 10.1192/bjp.bp.108.060723

C. N. Ramchand, J. I. Davies, R. L. Tresman, I. C. Griffiths, and M. Peet, Reduced susceptibility to oxidative damage of erythrocyte membranes from medicated schizophrenic patients, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.55, issue.1-2, pp.27-31, 1996.
DOI : 10.1016/S0952-3278(96)90142-8

A. Riecher-rössler, W. Rössler, H. Förstl, and U. Meise, Late-onset Schizophrenia and Late Paraphrenia, Schizophrenia Bulletin, vol.21, issue.3, pp.345-354, 1995.
DOI : 10.1093/schbul/21.3.345

P. J. Roberts and S. W. Davies, Excitatory receptors and their role in excitotoxicity, Biochemical Society Transactions, vol.15, issue.2, pp.218-219, 1987.
DOI : 10.1042/bst0150218

J. M. Robinson, H. Seguchi, and J. A. Badwey, Active oxygen and nitrogen species in biology: from cytocidal agents to signaling intermediates, Histochemistry and Cell Biology, vol.37, issue.4, pp.273-275, 2004.
DOI : 10.1007/s00418-004-0702-0

A. Rodová, J. Svestka, K. Náhunek, and E. Cesková, A blind comparison of clozapine and perphenazine in schizophrenics, Act Nerv Super (Praha), vol.15, pp.94-95, 1973.

B. Rolland, K. Marche, O. Cottencin, and R. Bordet, Agonist Fenofibrate Reduces Prepulse Inhibition Disruption in a Neurodevelopmental Model of Schizophrenia, Schizophrenia Research and Treatment, vol.674, issue.15, pp.1-5, 2012.
DOI : 10.1016/j.biopsych.2010.04.016

E. T. Rolls, M. Loh, G. Deco, and G. Winterer, Computational models of schizophrenia and dopamine modulation in the prefrontal cortex, Nature Reviews Neuroscience, vol.12, issue.9, pp.696-709, 2008.
DOI : 10.1038/nrn2462

L. E. Rueter, M. E. Ballard, K. B. Gallagher, A. M. Basso, P. Curzon et al., Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia, Psychopharmacology, vol.141, issue.3-4, pp.312-319, 2004.
DOI : 10.1007/s00213-004-1897-4

A. T. Russell, The Clinical Presentation of Childhood-Onset Schizophrenia, Schizophrenia Bulletin, vol.20, issue.4, pp.631-646, 1994.
DOI : 10.1093/schbul/20.4.631

F. Sams-dodd, B. K. Lipska, and D. R. Weinberger, Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood, Psychopharmacology, vol.132, issue.3, pp.303-310, 1997.
DOI : 10.1007/s002130050349

N. Santana, E. Troyano-rodriguez, G. Mengod, P. Celada, and F. Artigas, Activation of Thalamocortical Networks by the N-methyl-D-aspartate Receptor Antagonist Phencyclidine: Reversal by Clozapine, Biological Psychiatry, vol.69, issue.10, pp.918-927, 2011.
DOI : 10.1016/j.biopsych.2010.10.030

B. G. Schimmelmann, P. Conus, S. Cotton, P. D. Mcgorry, and M. Lambert, Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients, Schizophrenia Research, vol.95, issue.1-3, pp.1-8, 2007.
DOI : 10.1016/j.schres.2007.06.004

G. J. Schmitt, E. M. Meisenzahl, T. Frodl, L. Fougère, C. Hahn et al., Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [123I]IBZM SPECT, Psychiatry Research: Neuroimaging, vol.173, issue.3, pp.183-189, 2009.
DOI : 10.1016/j.pscychresns.2008.11.001

M. Schneider and M. Koch, Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in rats, Experimental Neurology, vol.195, issue.1, pp.185-198, 2005.
DOI : 10.1016/j.expneurol.2005.04.014

A. Schotte, P. F. Janssen, W. Gommeren, W. H. Luyten, P. Van-gompel et al., Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding, Psychopharmacology, vol.269, issue.Suppl 1, pp.57-73, 1996.
DOI : 10.1007/BF02245606

L. Schwieler, K. R. Linderholm, L. K. Nilsson-todd, S. Erhardt, and G. Engberg, Clozapine interacts with the glycine site of the NMDA receptor: Electrophysiological studies of dopamine neurons in the rat ventral tegmental area, Life Sciences, vol.83, issue.5-6, pp.170-175, 2008.
DOI : 10.1016/j.lfs.2008.05.014

P. Seeman, Atypical antipsychotics: mechanism of action, Can J Psychiatry, vol.47, pp.27-38, 2002.

P. Seeman, M. Chau-wong, J. Tedesco, and K. Wong, Brain receptors for antipsychotic drugs and dopamine: direct binding assays., Proceedings of the National Academy of Sciences, vol.72, issue.11, pp.4376-4380, 1975.
DOI : 10.1073/pnas.72.11.4376

P. Seeman, H. Guan, and H. Hirbec, receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil, Synapse, vol.38, issue.8, pp.698-704, 2009.
DOI : 10.1002/syn.20647

P. Seeman and T. Lee, Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons, Science, vol.188, issue.4194, pp.1217-1219, 1975.
DOI : 10.1126/science.1145194

Y. Sekine, M. Iyo, Y. Ouchi, T. Matsunaga, H. Tsukada et al., Methamphetamine-Related Psychiatric Symptoms and Reduced Brain Dopamine Transporters Studied With PET, American Journal of Psychiatry, vol.158, issue.8, pp.1206-1214, 2001.
DOI : 10.1176/appi.ajp.158.8.1206

P. D. Shilling, R. L. Saint-marie, J. M. Shoemaker, and N. R. Swerdlow, Strain Differences in the Gating-Disruptive Effects of Apomorphine: Relationship to Gene Expression in Nucleus Accumbens Signaling Pathways, Biological Psychiatry, vol.63, issue.8, pp.748-758, 2008.
DOI : 10.1016/j.biopsych.2007.10.015

E. H. Simpson, C. Kellendonk, and E. Kandel, A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia, Neuron, vol.65, issue.5, pp.585-596, 2010.
DOI : 10.1016/j.neuron.2010.02.014

S. Sorce, K. Krause, and V. Jaquet, Targeting NOX enzymes in the central nervous system: therapeutic opportunities, Cellular and Molecular Life Sciences, vol.40, issue.Suppl 2, pp.2387-2407, 2012.
DOI : 10.1007/s00018-012-1014-5

W. Stojanov, F. Karayanidis, P. Johnston, A. Bailey, V. Carr et al., Disrupted sensory gating in pathological gambling, Biological Psychiatry, vol.54, issue.4, pp.474-484, 2003.
DOI : 10.1016/S0006-3223(02)01745-6

N. R. Swerdlow, D. L. Braff, M. A. Geyer, and G. F. Koob, Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics, Biological Psychiatry, vol.21, issue.1, pp.23-33, 1986.
DOI : 10.1016/0006-3223(86)90005-3

N. R. Swerdlow, D. L. Braff, V. L. Masten, and M. A. Geyer, Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens, Psychopharmacology, vol.234, issue.3, pp.414-420, 1990.
DOI : 10.1007/BF02244063

N. R. Swerdlow, D. L. Braff, N. Taaid, and M. A. Geyer, Assessing the Validity of an Animal Model of Deficient Sensorimotor Gating in Schizophrenic Patients, Archives of General Psychiatry, vol.51, issue.2, pp.139-154, 1994.
DOI : 10.1001/archpsyc.1994.03950020063007

N. R. Swerdlow, R. S. Mansbach, M. A. Geyer, L. Pulvirenti, G. F. Koob et al., Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine, Psychopharmacology, vol.234, issue.3, pp.413-416, 1990.
DOI : 10.1007/BF02244616

J. Talairach and P. Tournoux, Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System : An Approach to Cerebral Imaging, 1988.

C. A. Tamminga and J. M. Davis, The Neuropharmacology of Psychosis, Schizophrenia Bulletin, vol.33, issue.4, pp.937-946, 2007.
DOI : 10.1093/schbul/sbm063

A. M. Thomson, D. C. West, and D. Lodge, An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?, Nature, vol.1, issue.6002, pp.479-481, 1985.
DOI : 10.1038/313479a0

K. Tseng, B. L. Lewis, B. K. Lipska, and P. O-'donnell, Post-Pubertal Disruption of Medial Prefrontal Cortical Dopamine???Glutamate Interactions in a Developmental Animal Model of Schizophrenia, Biological Psychiatry, vol.62, issue.7, pp.730-738, 2007.
DOI : 10.1016/j.biopsych.2006.10.012

K. Y. Tseng, R. A. Chambers, and B. K. Lipska, The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia, Behavioural Brain Research, vol.204, issue.2, pp.295-305, 2009.
DOI : 10.1016/j.bbr.2008.11.039

V. Uribe, B. K. Wong, R. K. Graham, C. L. Cusack, N. H. Skotte et al., Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice, Human Molecular Genetics, vol.21, issue.9, pp.1954-1967, 2012.
DOI : 10.1093/hmg/dds005

I. V. Vahia, B. W. Palmer, C. Depp, I. Fellows, S. Golshan et al., Is late-onset schizophrenia a subtype of schizophrenia?, Acta Psychiatrica Scandinavica, vol.11, issue.5, pp.414-426, 2010.
DOI : 10.1111/j.1600-0447.2010.01552.x

M. Van-den-buuse, B. Garner, and M. Koch, Neurodevelopmental Animal Models of Schizophrenia: Effects on Prepulse Inhibition, Current Molecular Medicine, vol.3, issue.5, pp.459-471, 2003.
DOI : 10.2174/1566524033479627

J. Van-os and S. Kapur, Schizophrenia, The Lancet, vol.374, issue.9690, pp.635-645, 2009.
DOI : 10.1016/S0140-6736(09)60995-8

URL : https://hal.archives-ouvertes.fr/hal-01382569

J. M. Van-rossum, The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs, Arch Int Pharmacodyn Ther, vol.160, pp.492-494, 1966.

D. Velakoulis, S. J. Wood, M. T. Wong, P. D. Mcgorry, A. Yung et al., Hippocampal and Amygdala Volumes According to Psychosis Stage and Diagnosis, Archives of General Psychiatry, vol.63, issue.2, pp.139-149, 2006.
DOI : 10.1001/archpsyc.63.2.139

P. B. Verghese, Y. Sasaki, D. Yang, F. Stewart, F. Sabar et al., Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death, Proceedings of the National Academy of Sciences, vol.108, issue.47, pp.19054-19059, 2011.
DOI : 10.1073/pnas.1107325108

X. Wang, P. Zhong, Z. Gu, and Z. Yan, Regulation of NMDA receptors by dopamine D4 signaling in prefrontal cortex, J. Neurosci, vol.23, pp.9852-9861, 2003.

D. R. Weinberger, Implications of Normal Brain Development for the Pathogenesis of Schizophrenia, Archives of General Psychiatry, vol.44, issue.7, pp.660-669, 1987.
DOI : 10.1001/archpsyc.1987.01800190080012

D. R. Weinberger, K. F. Berman, and R. F. Zec, Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia, Archives of General Psychiatry, vol.43, issue.2, pp.114-124, 1986.
DOI : 10.1001/archpsyc.1986.01800020020004

I. Weiner, R. E. Lubow, and J. Feldon, Disruption of latent inhibition by acute administration of low doses of amphetamine, Pharmacology Biochemistry and Behavior, vol.30, issue.4, pp.871-878, 1988.
DOI : 10.1016/0091-3057(88)90113-X

C. G. Wible, J. Anderson, M. E. Shenton, A. Kricun, Y. Hirayasu et al., Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study, Psychiatry Research: Neuroimaging, vol.108, issue.2, pp.65-78, 2001.
DOI : 10.1016/S0925-4927(01)00109-3

S. Wilk, E. Watson, and M. E. Stanley, Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine, J. Pharmacol. Exp. Ther, vol.195, pp.265-270, 1975.

A. Wilmsmeier, P. Ohrmann, T. Suslow, A. Siegmund, K. Koelkebeck et al., Neural correlates of set-shifting: decomposing executive functions in schizophrenia, Journal of Psychiatry and Neuroscience, vol.35, issue.5, pp.321-329, 2010.
DOI : 10.1503/jpn.090181

R. Wolf, K. Matzke, K. Paelchen, H. Dobrowolny, B. Bogerts et al., Reduction of Prepulse Inhibition (PPI) after Neonatal Excitotoxic Lesion of the Ventral Thalamus in Pubertal and Adult Rats, Pharmacopsychiatry, vol.43, issue.03, pp.99-109, 2010.
DOI : 10.1055/s-0029-1242823

G. K. Wood, B. K. Lipska, and D. R. Weinberger, Behavioral changes in rats with early ventral hippocampal damage vary with age at damage, Developmental Brain Research, vol.101, issue.1-2, pp.17-25, 1997.
DOI : 10.1016/S0165-3806(97)00050-3

N. D. Woodward, B. Waldie, B. Rogers, P. Tibbo, P. Seres et al., Abnormal prefrontal cortical activity and connectivity during response selection in first episode psychosis, chronic schizophrenia, and unaffected siblings of individuals with schizophrenia, Schizophrenia Research, vol.109, issue.1-3, pp.182-190, 2009.
DOI : 10.1016/j.schres.2008.11.028

K. Yamada, S. Kanba, S. Anamizu, K. Ohnishi, I. Ashikari et al., BRIEF COMMUNICATION, Psychological Medicine, vol.27, issue.5, pp.1223-1225, 1997.
DOI : 10.1017/S0033291797005114

Y. Yang, S. J. Fung, A. Rothwell, S. Tianmei, and C. S. Weickert, Increased Interstitial White Matter Neuron Density in the Dorsolateral Prefrontal Cortex of People with Schizophrenia, Biological Psychiatry, vol.69, issue.1, pp.63-70, 2011.
DOI : 10.1016/j.biopsych.2010.08.020

A. R. Yung, L. J. Phillips, H. P. Yuen, S. M. Francey, C. A. Mcfarlane et al., Psychosis prediction: 12-month follow up of a high-risk (???prodromal???) group, Schizophrenia Research, vol.60, issue.1, pp.21-32, 2003.
DOI : 10.1016/S0920-9964(02)00167-6

X. Y. Zhang, D. F. Zhou, L. Y. Cao, P. Y. Zhang, G. Y. Wu et al., Changes in Serum Interleukin-2, -6, and -8 Levels Before and During Treatment With Risperidone and Haloperidol, The Journal of Clinical Psychiatry, vol.65, issue.7, pp.940-947, 2004.
DOI : 10.4088/JCP.v65n0710

X. Zhao, Z. Ou, J. C. Grotta, N. Waxham, and J. Aronowski, Peroxisome-proliferator-activated receptorgamma (PPARgamma) activation protects neurons from NMDA excitotoxicity, Brain Res, pp.1073-1074, 2006.

T. B. Ziermans, P. F. Schothorst, M. Sprong, M. J. Magnée, H. Van-engeland et al., Reduced prepulse inhibition as an early vulnerability marker of the psychosis prodrome in adolescence, Schizophrenia Research, vol.134, issue.1, pp.10-15, 2012.
DOI : 10.1016/j.schres.2011.10.009